Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01096316 · ClinicalTrials.gov registry record · NA

Depression Attention for Women Now (The DAWN Study)

A NA study of Depressive Disorder, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
205
Enrollment target
2
Study locations

NCT01096316 is a NA study of Depressive Disorder that has completed, run by University of Washington. The registered enrollment target is 205 participants, below the 327-participant average among 47 other Depressive Disorder trials with a reported enrollment target (37% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01096316, a NA study of Depressive Disorder, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
2
Study locations

Study Summary

Major depressive disorder (MDD) is a common disabling illness that disproportionately affects women, with prevalence rates two times those of men. In addition to suffering, MDD has been shown to have a marked effect on social and vocational functioning, with increased disability, lost productivity, and excess mortality. Women with MDD have an increased prevalence of comorbid anxiety disorders and medical conditions. Our model of care utilizes a social worker as a depression care manager (DCM) to support both patients and physicians in optimizing care in the OB-GYN clinical setting. This intervention will be compared to usual care for depression.

Conditions Studied

Interventions

  • BEHAVIORAL Depression Care Management

Study Locations (2)

Washington

  • Women's Clinic at Harborview Medical Center - Seattle
  • Women's Health Care Center at University of Washington Medical Center (Roosevelt Clinic) - Seattle

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2009-11
Est. Completion 2015-05
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01096316

The ClinicalTrials.gov registry entry for NCT01096316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 327-participant average among 47 other Depressive Disorder trials with a reported enrollment target (37% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Depression Care Management is the first listed.

NCT01096316 reports 2 study locations spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01096316 about?

NCT01096316 is a clinical study titled "Depression Attention for Women Now (The DAWN Study)". Major depressive disorder (MDD) is a common disabling illness that disproportionately affects women, with prevalence rates two times those of men. In addition to suffering, MDD has been shown to have a marked effect on social and vocational functioning, with increased disability, lost productivity, ...

What is the current status of trial NCT01096316?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2009-11. Estimated completion is 2015-05.

What conditions does trial NCT01096316 study?

This clinical trial studies the following conditions: Depressive Disorder.

What interventions are being tested in trial NCT01096316?

The interventions under investigation include: Depression Care Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01096316?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01096316 being conducted?

This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.